Abstract

Citations (2)

Footnotes (144)

Using the URL or DOI link below will
ensure access to this page indefinitely

Based on your IP address, your paper is being delivered by:

New York, USA

Processing request.

Illinois, USA

Processing request.

Brussels, Belgium

Processing request.

Seoul, Korea

Processing request.

California, USA

Processing request.

If you have any problems downloading this paper,please click on another Download Location above, or view our FAQFile name: SSRN-id2085424. ; Size: 368K

You will receive a perfect bound, 8.5 x 11 inch, black and white printed copy of this PDF document with a glossy color cover. Currently shipping to U.S. addresses only. Your order will ship within 3 business days. For more details, view our FAQ.

Quantity:Total Price = $9.99 plus shipping (U.S. Only)

If you have any problems with this purchase, please contact us for assistance by email: Support@SSRN.com or by phone: 877-SSRNHelp (877 777 6435) in the United States, or +1 585 442 8170 outside of the United States. We are open Monday through Friday between the hours of 8:30AM and 6:00PM, United States Eastern.

An FDA for Financial Innovation: Applying the Insurable Interest Doctrine to 21st Century Financial Markets

The financial crisis of 2008 was caused in part by speculative investment in complex derivatives. In enacting the Dodd-Frank Act, Congress sought to address the problem of speculative investment, but merely transferred that authority to various agencies, which have not yet found a solution. We propose that when firms invent new financial products, they be forbidden to sell them until they receive approval from a government agency designed along the lines of the FDA, which screens pharmaceutical innovations. The agency would approve financial products if they satisfy a test for social utility that focuses on whether the product will likely be used more often for insurance than for gambling. Other factors may be addressed if the answer is ambiguous. This approach would revive and make quantitatively precise the common-law insurable interest doctrine, which helped control financial gambling before deregulation in the 1990s.

Date posted: February 25, 2012
; Last revised: July 30, 2013

Suggested Citation

Posner, Eric A. and Weyl, E. Glen, An FDA for Financial Innovation: Applying the Insurable Interest Doctrine to 21st Century Financial Markets (June 4, 2012). Northwestern University Law Review, Vol. 107, Forthcoming; University of Chicago Institute for Law & Economics Olin Research Paper No. 589; U of Chicago, Public Law Working Paper No. 382. Available at SSRN: http://ssrn.com/abstract=2010606 or http://dx.doi.org/10.2139/ssrn.2010606